Clinical Trial Update: Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial of decitabine in patients with myelodysplastic syndromes or acute myeloid leukemia; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1 | Status: TERMINATED